within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01E_SulfonamidesAndTrimethoprim.J01EB04_Sulfapyridine;

model Sulfapyridine
  extends Pharmacolibrary.Drugs.ATC.J.J01EB04;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J01EB04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Sulfapyridine is a sulfonamide antibacterial drug that was historically used to treat bacterial infections, particularly in the pre-penicillin era. It is a synthetic antimicrobial agent. Its use has largely declined due to the development of more effective and less toxic antibiotics, though it is sometimes still encountered as a metabolite of sulfasalazine, a drug used for rheumatoid arthritis and inflammatory bowel disease.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are reported for healthy adult volunteers following oral administration.</p><h4>References</h4><ol><li><p>Awni, WM, Braeckman, RA, Locke, CS, Dubé, LM, &amp; Granneman, GR (1995). The influence of multiple oral doses of zileuton on the steady-state pharmacokinetics of sulfasalazine and its metabolites, sulfapyridine and N-acetylsulfapyridine. <i>Clinical pharmacokinetics</i> 29 Suppl 2 98–104. DOI:<a href=\"https://doi.org/10.2165/00003088-199500292-00014\">10.2165/00003088-199500292-00014</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8620678/\">https://pubmed.ncbi.nlm.nih.gov/8620678</a></p></li><li><p>Bates, TR, Blumenthal, HP, &amp; Pieniaszek, HJ (1977). Salivary excretion and pharmacokinetics of sulfapyridine after sulfasalazine. <i>Clinical pharmacology and therapeutics</i> 22(6) 917–927. DOI:<a href=\"https://doi.org/10.1002/cpt1977226917\">10.1002/cpt1977226917</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21768/\">https://pubmed.ncbi.nlm.nih.gov/21768</a></p></li><li><p>Tett, SE (1993). Clinical pharmacokinetics of slow-acting antirheumatic drugs. <i>Clinical pharmacokinetics</i> 25(5) 392–407. DOI:<a href=\"https://doi.org/10.2165/00003088-199325050-00005\">10.2165/00003088-199325050-00005</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7904547/\">https://pubmed.ncbi.nlm.nih.gov/7904547</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Sulfapyridine;
